Home > Infectious Diseases > Tuberculosis Prevention and Control > Tuberculosis: Drug resistance in Canada – 2012 > APPENDIX 1 > Text Equivalents
| Province/territory | Number of reported isolates |
|---|---|
| Ont. | 493 |
| B.C. | 254 |
| Que. | 209 |
| Alta. | 163 |
| Man. | 123 |
| Sask. | 72 |
| Nvt. | 65 |
| N.S. | 9 |
| N.W.T | 6 |
| N.L. | 5 |
| N.B. | 4 |
| P.E.I. | 0 |
| Y.T. | 1 |
| Type of Drug | Drug resistance (%) |
|---|---|
| Any resistance to INH | 7.9 |
| Any resistance to RMP | 0.6 |
| Any resistance to EMB | 0.3 |
| Any resistance to PZA | 2.8 |
Return to the Figure 2: Reported TB drug resistance in Canada by type of first-line drug: 2012
| Any resistance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INH | 8.1 | 9.4 | 7.3 | 8.2 | 7.3 | 8.7 | 7.5 | 8.5 | 7.9 | 9.2 | 7.9 |
| RMP | 1.7 | 1.6 | 1.0 | 1.8 | 1.7 | 1.0 | 1.4 | 1.6 | 1.4 | 1.6 | 0.6 |
| EMB | 1.8 | 1.2 | 0.8 | 1.5 | 0.9 | 1.8 | 1.0 | 1.3 | 0.8 | 0.7 | 0.3 |
| PZA | 2.6 | 2.6 | 2.4 | 2.1 | 1.5 | 2.7 | 2.1 | 1.7 | 2.4 | 2.6 | 2.8 |
| Type of resistance | Drug resistance (%) |
|---|---|
| Resistant to one or more drugs | 9.8 |
| Monoresistant | 9.0 |
| MDR-TB* | 0.6 |
| XDR-TB† | 0.1 |
| Other Patterns | 0.1 |
Return to the Figure 4: Overall pattern of reported TB drug resistance in Canada: 2012
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resistance to one or more drugs | 9.8 | 10.5 | 8.6 | 9.6 | 9.1 | 10.5 | 8.6 | 9.5 | 8.8 | 10.5 | 9.8 |
| Monoresistance | 7.7 | 8.3 | 6.8 | 7.7 | 7.7 | 8.8 | 6.9 | 7.4 | 6.9 | 9.0 | 9.0 |
| MDR-TB* | 1.4 | 1.4 | 0.9 | 1.6 | 1.1 | 0.9 | 1.1 | 1.4 | 1.3 | 1.4 | 0.6 |
| Other Patterns | 0.6 | 0.7 | 0.9 | 0.2 | 0.2 | 0.9 | 0.4 | 0.8 | 0.5 | 0.1 | 0.1 |
| XDR-TB† | 0.1 | 0.1 | - | - | 0.1 | - | 0.1 | - | 0.1 | 0.1 | 0.1 |
This map of Canada, with the provinces and territories variously highlighted, shows the highest level of drug-resistance reported from each province and territory for 2012. Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Prince Edward Island and Yukon are shaded white indicating that all isolates tested were susceptible to all first-line drugs. Manitoba, New Brunswick, Quebec and Saskatchewan are shaded light blue indicating that, of all the results reported, at least one of the isolates tested in each province was resistant to one or more of the TB drugs but does not include the isoniazid and rifampin combination. Alberta, British Columbia and Ontario are shaded dark blue, indicating that of all the results reported that at least one isolate tested from each province was identified as either MDR-TB or XDR-TB.
Return to the Figure 6: Reported TB drug resistance in Canada by province/territory: 2012